8월 . 27, 2025 04:40 Back to list
The albendazole tablet represents a cornerstone in the global effort to combat parasitic helminth infections, offering a broad-spectrum anthelminthic solution critical for both human and veterinary health. As a benzimidazole derivative, it functions by inhibiting microtubule polymerization, leading to the depletion of energy reserves and subsequent death of the parasite. This detailed overview focuses on the technical intricacies, market dynamics, and operational advantages associated with the production and application of this vital pharmaceutical product. We aim to provide B2B decision-makers, procurement specialists, and healthcare professionals with comprehensive insights into its manufacturing excellence, quality assurance, and diverse utility, emphasizing why it remains a preferred choice in combating a wide range of helminthic infestations.
The global market for anthelmintics, specifically those containing albendazole tablet formulations, is experiencing steady growth driven by several key factors. Increased awareness campaigns for neglected tropical diseases (NTDs), particularly in endemic regions, continue to fuel demand for mass drug administration (MDA) programs. Furthermore, the rising prevalence of parasitic infections in livestock and companion animals underscores the expanding market for albendazole tablets for dogs and other animals. Technological advancements in drug delivery systems and formulation stability are also contributing to market expansion.
Recent market analysis indicates a compound annual growth rate (CAGR) of approximately 4.5% for the anthelminthic drugs segment, with projections suggesting sustained growth through 2030. This growth is predominantly observed in regions with high parasitic infection burdens, such as Sub-Saharan Africa, Latin America, and parts of Asia. Regulatory support from organizations like the World Health Organization (WHO) and regional health ministries, which advocate for accessible and affordable treatments, significantly impacts the adoption and distribution of albendazole tablets. The emphasis on high-quality generics, including those meeting the specifications of albendazole tablets IP (Indian Pharmacopoeia), further ensures broader availability and affordability.
Manufacturers are increasingly investing in robust supply chain management and Good Manufacturing Practice (GMP) compliant facilities to meet the growing demand while adhering to stringent international quality standards. The focus is not just on production volume but also on enhancing the bioavailability and patient compliance of albendazole tablet formulations.
Understanding the technical specifications of a pharmaceutical product like the albendazole tablet is paramount for ensuring efficacy, safety, and regulatory compliance. Albendazole is chemically designated as methyl 5-(propylthio)-2-benzimidazolecarbamate. Its anthelminthic action is primarily attributed to its active metabolite, albendazole sulfoxide, which selectively binds to parasitic beta-tubulin, disrupting microtubule formation and impairing glucose uptake, leading to parasite starvation.
Key parameters include API purity, dissolution rates, disintegration time, and uniform content. Our manufacturing processes ensure strict adherence to these critical quality attributes, facilitating optimal therapeutic outcomes. The tablets are typically formulated for oral administration, often in chewable or film-coated forms to enhance patient compliance, particularly in pediatric or veterinary applications where administering albendazole tablets for dogs or young children can be challenging.
Parameter | Specification | Standard |
---|---|---|
Active Pharmaceutical Ingredient (API) | Albendazole (min 98.0% assay) | USP / BP / IP |
Dosage Strength | 200 mg, 400 mg (common) | Pharmacopoeial Monograph |
Excipients | Lactose, Microcrystalline Cellulose, Maize Starch, Sodium Starch Glycolate, Magnesium Stearate, Colloidal Silicon Dioxide (typical) | FDA / EMA Approved |
Appearance | White to off-white, round, biconvex tablet, scored | Visual Inspection |
Disintegration Time | NMT 15 minutes (uncoated), NMT 30 minutes (coated) | USP / BP |
Dissolution Rate | NLT 75% in 45 minutes | USP / BP |
Uniformity of Content | Meets pharmacopoeial requirements (85-115% of label claim) | USP / BP |
Shelf Life | 3-5 years, depending on storage conditions | ICH Guidelines (Q1A) |
Storage Conditions | Store below 30°C in a dry place, protect from light | Pharmacopoeial / Stability Data |
Note: USP = United States Pharmacopeia, BP = British Pharmacopoeia, IP = Indian Pharmacopoeia, NMT = Not More Than, NLT = Not Less Than, ICH = International Council for Harmonisation.
The production of a high-quality albendazole tablet adheres to rigorous pharmaceutical manufacturing standards, typically following a detailed process flow designed to ensure purity, potency, and consistent dissolution profiles. Our facilities operate under strict Good Manufacturing Practices (GMP) and are often certified to ISO 9001:2015, ensuring product quality and traceability at every stage.
High-purity Albendazole API, excipients (binders, disintegrants, lubricants, diluents like lactose or microcrystalline cellulose). All materials undergo stringent testing (e.g., identity, purity, heavy metals, microbial limits) per USP, BP, or IP standards before release for production.
Precise weighing of API and excipients using calibrated scales. Materials are then uniformly blended in a suitable mixer (e.g., V-blender, ribbon blender) to ensure homogeneity, a critical step for content uniformity.
Wet Granulation: API and excipients mixed with a binder solution, then dried and milled into granules. Dry Granulation (Roller Compaction/Slugging): Materials compressed into slugs/ribbons, then milled. This enhances flowability and compressibility, crucial for tablet quality.
Granules are blended with lubricants (e.g., magnesium stearate) and disintegrants (e.g., sodium starch glycolate) to ensure smooth tablet ejection from the press and proper disintegration post-ingestion.
The blended mixture is fed into high-speed tablet compression machines. Parameters such as hardness, thickness, and weight are continuously monitored and adjusted to ensure consistent tablet quality and dosage accuracy.
Tablets may undergo film coating for aesthetic appeal, taste masking, ease of swallowing, or enhanced stability. Aqueous film coating solutions are applied in specialized coating pans, followed by drying.
Finished tablets are packaged into blister packs, bottles, or other suitable containers, followed by labeling with batch numbers, expiry dates, and regulatory information. Automated vision systems ensure label accuracy.
Tablets undergo final QC tests including assay, dissolution, disintegration, microbial limits, and stability testing. Only batches meeting all specifications (e.g., ISO, ICH) are released for distribution.
The typical service life of an albendazole tablet refers to its shelf life, which ranges from 3 to 5 years when stored under specified conditions (e.g., below 30°C, protected from light and moisture). This ensures the product maintains its efficacy and safety throughout its labeled period. Target industries for our high-quality albendazole tablets include humanitarian aid organizations, national public health programs, veterinary pharmaceutical distributors, and private healthcare providers in both human and animal health sectors. Our manufacturing advantages include energy-efficient processes and robust quality control, leading to products with superior dissolution profiles and enhanced bioavailability.
The versatility of the albendazole tablet makes it indispensable across various sectors. Its broad-spectrum efficacy targets numerous helminthic infections, positioning it as a first-line treatment in diverse clinical and public health settings.
In typical application scenarios, such as large-scale deworming campaigns, the reliability and cost-effectiveness of high-quality albendazole tablets are paramount. Our manufacturing processes ensure excellent shelf stability and consistent potency, which is critical for distributing large quantities to remote areas. This contributes to better patient outcomes and public health improvements globally, providing energy-saving treatment through efficient logistics and corrosion-resistance in terms of chemical stability against degradation.
Our commitment to advanced pharmaceutical science and rigorous quality control results in a superior albendazole tablet that offers distinct technical advantages. These benefits translate directly into enhanced therapeutic efficacy and improved patient compliance, making our product a preferred choice for healthcare providers and distributors.
These technical advantages underscore our commitment to delivering a reliable and highly effective albendazole tablet, designed to meet the stringent demands of healthcare professionals and public health initiatives worldwide.
When sourcing albendazole tablets, B2B buyers must critically evaluate suppliers based on a comprehensive set of criteria that extend beyond mere pricing. Key factors include manufacturing quality, regulatory compliance, supply chain reliability, and the ability to offer tailored solutions. The difference between a standard generic and a premium generic (e.g., specific albendazole tablets IP) can significantly impact public health outcomes and cost-effectiveness over the long term.
Feature | Our Offering (Skyvet Pharm) | Standard Generic Vendor | Budget/Local Vendor |
---|---|---|---|
Regulatory Compliance | GMP, ISO 9001:2015, WHO-PQ standards. Often exceeds pharmacopoeial limits. | GMP compliant (local standard), adheres to basic pharmacopoeial limits. | May meet minimal local standards, less international certification. |
API Purity & Sourcing | >99% purity from audited, long-term partners. | ~98% purity, varied sourcing. | Variable purity, less stringent sourcing. |
Dissolution Profile | Consistently meets/exceeds pharmacopoeial dissolution rates (NLT 85% in 30 min). | Meets pharmacopoeial minimum (NLT 75% in 45 min). | May show variability, sometimes at borderline. |
Stability & Shelf Life | Proven 3-5 years under ICH conditions, advanced packaging. | Typically 2-3 years, standard packaging. | Shorter shelf life, potentially poorer stability. |
Customization & Flexibility | High capacity for custom dosages, packaging, and specific formulation requests. | Limited customization, primarily standard SKUs. | Very limited or no customization. |
Customer Support & Lead Time | Dedicated support, consistent lead times, strong logistics network. | Standard support, variable lead times. | Minimal support, inconsistent lead times. |
Choosing the right vendor for your albendazole tablet needs involves a strategic decision that prioritizes not just cost, but also quality, reliability, and long-term partnership potential. Our adherence to stringent quality controls and consistent production capabilities ensures a superior product that aligns with global health initiatives and veterinary care standards.
Recognizing the diverse requirements of our B2B partners, we offer comprehensive customization options for our albendazole tablet formulations. These bespoke solutions are designed to meet specific market demands, regulatory landscapes, and patient demographics, ensuring optimal utility and market penetration.
Our agile manufacturing capabilities and dedicated R&D team are poised to collaborate with clients to transform their specific requirements into high-quality, market-ready albendazole tablet solutions, ensuring successful product launches and sustained market presence.
The proven efficacy and widespread adoption of the albendazole tablet are best illustrated through real-world application scenarios, demonstrating its profound impact on public and animal health globally.
A major international non-governmental organization (INGO) partnered with us to procure millions of albendazole tablets for a comprehensive deworming program targeting school-aged children in several Southeast Asian countries. The program aimed to reduce the burden of soil-transmitted helminthiasis (STH), which significantly impacts children's health, education, and development. Our commitment to timely delivery, consistent product quality (meeting WHO-PQ standards), and robust packaging ensured that the tablets reached remote areas in optimal condition. Post-campaign evaluations showed a remarkable 70% reduction in STH prevalence across intervention areas, leading to improved school attendance, reduced anemia rates, and enhanced cognitive function among children. The reliability of our albendazole tablets was a critical factor in the success of this large-scale public health initiative.
A large-scale cattle farming operation faced significant economic losses due to helminth infections, particularly gastrointestinal nematodes, affecting herd health and productivity. Following a veterinary consultation, a regimen involving our specialized albendazole tablets for dogs (adapted for cattle with specific dosage guidance) was implemented. Our technical team provided support on optimal administration and resistance monitoring. Within two months, fecal egg counts in the herd decreased by over 90%, leading to noticeable improvements in weight gain, milk production, and overall animal health. The farmer reported a significant reduction in veterinary costs and a substantial increase in profitability, directly attributing the success to the consistent efficacy and quality of the albendazole tablet supplied.
In a rural hospital in a region endemic for neurocysticercosis, access to reliable anthelmintic treatment was a challenge. A local distributor chose our abz albendazole tablet due to its competitive pricing and guaranteed adherence to international pharmacopoeial standards (similar to albendazole tablets IP). The consistent quality of the product ensured effective treatment for patients suffering from neurological symptoms caused by the parasitic infection. The hospital's medical team reported positive patient outcomes, with many experiencing significant reduction in seizure frequency and improved quality of life, underscoring the vital role of dependable drug supply in managing complex parasitic diseases.
A1: Albendazole, and its active metabolite albendazole sulfoxide, exerts its anthelminthic effect by selectively binding to the beta-tubulin of parasites, inhibiting microtubule polymerization. This disrupts the parasite's cellular structure and metabolism, particularly glucose uptake, leading to its immobilization and eventual death.
A2: Yes, our albendazole tablets are widely used in veterinary applications. We can provide specific formulations, including those ideal for albendazole tablets for dogs, ensuring appropriate dosage and palatability while adhering to veterinary pharmacopoeial standards. Consultation with a veterinarian is always recommended for animal specific dosing.
A3: Our manufacturing facilities operate under strict Good Manufacturing Practices (GMP) and are ISO 9001:2015 certified. Our products, including albendazole tablets IP, frequently undergo audits by international regulatory bodies and comply with standards from WHO-PQ, USP, and BP.
A4: Absolutely. We offer extensive customization for bulk orders, including various packaging types (blister packs, bottles, bulk containers), specific labeling requirements, and options for client-specific branding. This flexibility applies to all formulations, including specialty items like abz albendazole tablet versions.
A5: Lead times vary based on order volume, customization requirements, and current production schedules. However, our standard lead time for established products typically ranges from 4-8 weeks from order confirmation to dispatch. For specific project timelines, please contact our sales team for a detailed assessment.
Our streamlined production and logistics ensure efficient order fulfillment for the albendazole tablet. For standard formulations and bulk orders, our typical lead time is between 6 to 10 weeks, depending on the volume and specific customization requests. Urgent orders or those requiring highly specialized formulations may have adjusted timelines. We maintain robust inventory management and strong relationships with raw material suppliers to minimize delays and ensure consistent supply, a crucial aspect for programs relying on regular supply of albendazole tablets. Our global distribution network facilitates timely delivery to diverse international destinations.
We stand behind the quality of every albendazole tablet we produce. All products are guaranteed to meet or exceed the specifications outlined in the Certificate of Analysis (CoA) and adhere to relevant pharmacopoeial standards (USP, BP, IP) throughout their stated shelf life, provided they are stored under recommended conditions. Our warranty covers manufacturing defects and failures to meet specified quality parameters. In the unlikely event of a quality concern, our dedicated quality assurance team will investigate promptly and provide appropriate resolutions in line with international regulatory guidelines.
Our commitment to our clients extends far beyond product delivery. We offer comprehensive customer support designed to foster long-term partnerships. This includes:
Our goal is to be more than just a supplier; we aim to be a trusted partner in your mission to deliver effective and safe pharmaceutical solutions, whether it's for human health, or for ensuring the health of animals with albendazole tablets for dogs and livestock.
The albendazole tablet stands as a critical and highly effective pharmaceutical solution for combating parasitic helminth infections across human and animal health sectors. Our unwavering commitment to manufacturing excellence, adherence to international quality standards, and ability to provide customized solutions distinguish us as a premier partner for B2B clients globally. By integrating rigorous process controls, leveraging advanced pharmaceutical technology, and offering comprehensive customer support, we ensure that our albendazole tablets consistently deliver superior efficacy, reliability, and value. Choosing our products means opting for a trusted partner dedicated to public health and animal welfare outcomes, supported by robust technical expertise and a proven track record.
Products categories